Ronald Todd Plott insider trades

Open-market stock purchases and sales by Ronald Todd Plott, Director at Phio Pharmaceuticals Corp, from SEC Form 4 filings since Feb 1, 2019.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -18%.

Recent trades

DateStockTradeValue
Sep 29, 2026PHIO Phio Pharmaceuticals CorpBought$5.2K
Sep 28, 2026PHIO Phio Pharmaceuticals CorpBought (not open market)—
Sep 28, 2026PHIO Phio Pharmaceuticals CorpBought$5.2K
Aug 19, 2026PHIO Phio Pharmaceuticals CorpBought$17.1K

Companies traded

  • PHIO Phio Pharmaceuticals Corp: 3 buys, last Sep 29, 2026
  • BPMX BioPharmX Corp: other filings, last Jun 12, 2019

Get free alerts when Ronald Todd Plott files a new trade →